(2R,3R,4S,5R)-2-(6-(CYCLOPENTYLAMINO)-9H-PURIN-9-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL, 95%, 5g

Hexyltriethoxysilane>97.0%(GC)25mL

4-Methylmorpholine 4-oxide monohydrate, 95.0%, 25g

[1,2,4]Triazolo[1,5-a]pyridine-2-carboxylic acid, 97%, 1g

3-(3-bromophenyl)-2'-chloropropiophenone, 97.0%, 1g

a-D-Xylopyranose, 95.0%, 500g

(R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)(METHYL)AMINO)-4-(TERT-BUTOXY)-4-OXOBUTANOIC ACID, 95%, 250mg

1-BENZYL-3-((TERT-BUTYLDIMETHYLSILYLOXY)METHYL)PIPERIDIN-4-OL, 95.0%, 1g

1-(Aminomethyl)cyclohexan-1-ol, 98%, 5g

2-Amino-3-chloro-5-nitropyridine, 95.0%, 10g

4,5,6,7-TETRAIODOISOBENZOFURAN-1,3-DIONE, 95%, 100mg

tert-Butyl 1-bromo-3,6,9,12,15,18,21,24-octaoxaheptacosan-27-oate, 95%, 1g

1,3-Dimethyl-5-nitro-1,3-dihydro-2H-benzo[d]imidazol-2-one, 97%, 5g